CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...
Phase 1, Phase 2
Chicago, Illinois, United States and 5 other locations
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Arlington Heights, Illinois, United States and 5 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Chicago, Illinois, United States and 135 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Chicago, Illinois, United States and 11 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Chicago, Illinois, United States and 70 other locations
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Arlington Heights, Illinois, United States and 35 other locations
cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...
Phase 1
Chicago, Illinois, United States and 41 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Chicago, Illinois, United States and 46 other locations
with renal cell carcinoma (RCC), urothelial carcinoma, all pancreatic cancers, endometrial cancer, and other solid tumors...
Phase 2
Chicago, Illinois, United States and 2 other locations
to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...
Phase 1
Chicago, Illinois, United States and 41 other locations
Clinical trials
Research sites
Resources
Legal